FLOW CYTOMETRY, CD 14

The Flow Cytometry CD14 Test is a specialized immunophenotyping assay used to detect and measure the expression of CD14, a cell surface marker primarily found on monocytes, macrophages, and related myeloid cells. CD14 plays an important role in the body's immune response by helping immune cells recognize bacterial components and initiate inflammatory reactions.

Flow cytometry is a highly advanced laboratory technique that analyzes thousands of cells individually within seconds. By identifying CD14-positive cells, the test helps evaluate monocyte populations and supports the diagnosis, classification, and monitoring of various hematological, immunological, and inflammatory conditions.

CD14 is commonly included in comprehensive flow cytometry panels used for the investigation of acute leukemias, chronic myelomonocytic disorders, myelodysplastic syndromes, and other bone marrow abnormalities. It is particularly valuable in identifying monocytic differentiation within abnormal cell populations.

The test is generally performed on blood, bone marrow aspirate, or other clinically appropriate specimens and is interpreted alongside additional flow cytometry markers to provide a complete immunophenotypic profile.

Benefits of the Test

• Identifies and quantifies monocyte populations
• Assists in leukemia immunophenotyping
• Helps evaluate myeloid and monocytic disorders
• Supports diagnosis of bone marrow diseases
• Assists disease classification and monitoring
• Provides valuable diagnostic information

Why Doctors Recommend This Test

Doctors may recommend Flow Cytometry CD14 testing for:

• Suspected acute leukemia
• Acute Monocytic Leukemia evaluation
• Acute Myelomonocytic Leukemia assessment
• Chronic Myelomonocytic Leukemia (CMML)
• Myelodysplastic syndrome investigation
• Abnormal blood counts
• Bone marrow disorder evaluation
• Comprehensive hematological immunophenotyping

The test helps determine the presence and characteristics of abnormal monocyte or myeloid cell populations.

Preparation Before Test

The test may require:

• Peripheral blood sample
• Bone marrow aspirate
• Other clinically relevant specimens

Preparation generally includes:

• No fasting is usually required
• Inform your physician about ongoing treatments
• Follow laboratory-specific collection instructions

The procedure involves routine specimen collection and advanced laboratory analysis.

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on laboratory workflow and the complexity of the immunophenotyping panel.

Who Should Take This Test?

• Patients with suspected leukemia
• Individuals with abnormal blood cell counts
• Patients undergoing bone marrow evaluation
• Individuals with suspected myeloid disorders
• Patients with unexplained hematological abnormalities
• Individuals referred by hematologists or oncologists

Flow Cytometry CD14 testing is an important diagnostic tool for evaluating monocyte-related disorders and hematological malignancies.

Clinical Significance

CD14 expression is commonly associated with:

• Normal Monocytes
• Acute Monocytic Leukemia (AML-M5)
• Acute Myelomonocytic Leukemia (AML-M4)
• Chronic Myelomonocytic Leukemia (CMML)
• Myelodysplastic Syndromes
• Myeloid Neoplasms
• Inflammatory and immune-mediated conditions

Abnormal CD14 expression patterns help identify monocytic lineage involvement and contribute to accurate disease classification.

Important Note

CD14 is rarely interpreted as a standalone marker. It is usually analyzed together with markers such as CD13, CD33, CD34, CD45, CD64, HLA-DR, CD11b, CD15, and CD117 to establish a comprehensive immunophenotypic diagnosis.